| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2023-04-14 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $536.00M | $494.80M | $557.10M | – | $563.20M | $473.30M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – |
| Operating Income | $101.20M | $90.60M | $87.10M | – | $80.50M | $77.80M |
| Interest Expense | $43.80M | $37.70M | $34.90M | – | $28.30M | $27.20M |
| Tax Expense | $15.30M | $14.00M | $13.20M | $9.40M | $11.20M | $11.50M |
| Net Income | $50.20M | $47.10M | $45.20M | – | $41.40M | $36.10M |
| EPS (basic) | 2.9700 | 2.9300 | 2.8200 | – | 2.5900 | 2.3500 |
| EPS (diluted) | 2.9700 | 2.9300 | 2.8200 | – | 2.5900 | 2.3500 |
| Shares (diluted) | $16.79M | $16.11M | $16.05M | – | $16.00M | $15.38M |